Brief: Dicot Pharma Q3 Loss After Financial Items SEK 16.1 Mln
23/10/2025 15:03
Oct 23 (Reuters) - Dicot Pharma AB DICOT.ST: Q3 EARNINGS AFTER FINANCIAL ITEMS AT SEK -16.1 MILLION Source text Further company coverage: DICOT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA